Johnson & Johnson (JNJ) Shares Outstanding: 2.43
Is Johnson & Johnson’s shares outstanding high or low?
Johnson & Johnson's shares outstanding of 2.43 is in line with its 5-year average of 2.54, near the low end of its 5-year range (2.41–2.63).
The shares outstanding for Johnson & Johnson (JNJ) is 2.43. It is above its 12-month average by 0.44% (2.42).
JNJ Shares Outstanding Chart
JNJ Average Shares Outstanding Chart
JNJ Current vs Average Shares Outstanding Chart
JNJ Shares Outstanding Metrics
SHARES OUTSTANDING
2.43
SHARES OUTSTANDING AVG TTM
2.42
SHARES OUTSTANDING AVG 3Y
2.50
SHARES OUTSTANDING AVG 5Y
2.54
SHARES OUTSTANDING AVG 10Y
2.61
SHARES OUTSTANDING AVG 15Y
2.66
SHARES OUTSTANDING AVG 20Y
2.71
CURRENT VS TTM AVG
+0.44%
CURRENT VS 3Y AVG
-2.69%
CURRENT VS 5Y AVG
-4.41%
CURRENT VS 10Y AVG
-6.86%
CURRENT VS 15Y AVG
-8.63%
CURRENT VS 20Y AVG
-10.37%
Share Structure
Shares Outstanding
2.43B
Float Shares
N/A
Stock Price
$237.00
Market Cap
$570.5B
Annual Shares Outstanding History
| Year | Weighted Average Shares | YoY Change |
|---|---|---|
| 2025 | 2.43B | +0.88% |
| 2024 | 2.41B | -7.89% |
| 2023 | 2.61B | +3.16% |
| 2023 | 2.53B | -3.63% |
| 2022 | 2.63B | -0.13% |
| 2021 | 2.63B | +0.00% |
| 2019 | 2.63B | -1.12% |
| 2018 | 2.66B | -0.75% |
| 2017 | 2.68B | -0.89% |
| 2016 | 2.71B | -1.77% |
| 2015 | 2.76B | -1.01% |
| 2014 | 2.78B | -1.33% |
| 2013 | 2.82B | +1.52% |
| 2012 | 2.78B | +1.99% |
| 2011 | 2.72B | -0.50% |
| 2010 | 2.74B | -0.79% |
| 2009 | 2.76B | -1.85% |
| 2008 | 2.81B | -2.46% |
| 2007 | 2.88B | -1.93% |
| 2006 | 2.94B | -1.23% |
| 2005 | 2.98B | +0.28% |
| 2004 | 2.97B | +0.00% |
| 2003 | 2.97B | -1.02% |
| 2002 | 3.00B | -1.07% |
| 2001 | 3.03B | +1.25% |
| 2000 | 2.99B | +0.18% |
| 1999 | 2.99B | +7.46% |
| 1998 | 2.78B | +3.97% |
| 1997 | 2.67B | +0.51% |
| 1996 | 2.66B | - |
Relationship: Market Cap = Shares Outstanding × Stock Price
Key concepts:
- Float shares: Shares available for public trading
- Dilution: When new shares are issued, existing shareholders own less
- Buybacks: Reduce share count, increasing EPS and ownership stake
- Stock splits: Increase share count but don't change market cap
Johnson & Johnson Shares Outstanding Formula & Definition
Shares Outstanding represents the total number of shares issued by a company that are held by all shareholders. Changes in share count affect EPS and ownership dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Johnson & Johnson Shares Outstanding FAQ
- What is the shares outstanding for Johnson & Johnson (JNJ)?
- The shares outstanding for JNJ stock is 2.43.
- Is Johnson & Johnson's shares outstanding high or low?
- Johnson & Johnson's shares outstanding of 2.43 is in line with its 5-year average of 2.54, near the low end of its 5-year range (2.41–2.63).
- What is the TTM average shares outstanding for Johnson & Johnson (JNJ)?
- The TTM average shares outstanding for JNJ stock is 2.42.
- What is the 3Y average shares outstanding for Johnson & Johnson (JNJ)?
- The 3Y average shares outstanding for JNJ stock is 2.50.
- What is the 5Y average shares outstanding for Johnson & Johnson (JNJ)?
- The 5Y average shares outstanding for JNJ stock is 2.54.
- What is the 10Y average shares outstanding for Johnson & Johnson (JNJ)?
- The 10Y average shares outstanding for JNJ stock is 2.61.
- What is the 15Y average shares outstanding for Johnson & Johnson (JNJ)?
- The 15Y average shares outstanding for JNJ stock is 2.66.
- What is the 20Y average shares outstanding for Johnson & Johnson (JNJ)?
- The 20Y average shares outstanding for JNJ stock is 2.71.
Johnson & Johnson Shares Outstanding History
| DATE | SHARES OUTSTANDING |
|---|---|
| 2025-12-28 | 2.43 |
| 2024-12-29 | 2.41 |
| 2023-12-31 | 2.53 |
| 2023-01-01 | 2.61 |
| 2022-01-02 | 2.63 |
| 2021-01-03 | 2.63 |
| 2019-12-31 | 2.63 |
| 2018-12-31 | 2.66 |
| 2017-12-31 | 2.68 |
| 2016-12-31 | 2.71 |
| 2015-12-31 | 2.76 |
| 2014-12-31 | 2.78 |
| 2013-12-31 | 2.82 |
| 2012-12-31 | 2.78 |
| 2011-12-31 | 2.72 |
| 2010-12-31 | 2.74 |
| 2009-12-31 | 2.76 |
| 2008-12-31 | 2.81 |
| 2007-12-31 | 2.88 |
| 2006-12-31 | 2.94 |
| 2005-12-31 | 2.98 |
| 2004-12-31 | 2.97 |
| 2003-12-31 | 2.97 |
| 2002-12-31 | 3.00 |
| 2001-12-31 | 3.03 |
| 2000-12-31 | 2.99 |
| 1999-12-31 | 2.99 |
| 1998-12-31 | 2.78 |
| 1997-12-31 | 2.67 |
| 1996-12-31 | 2.66 |
Related Metrics
About Johnson & Johnson
Johnson & Johnson (JNJ) operates globally, engaging in the research, development, production, and distribution of a diverse range of healthcare products. In a pivotal strategic move in 2023, the company divested its Consumer Health division, establishing it as the independent entity Kenvue Inc. This separation was implemented to allow J&J to sharpen its focus on higher-growth, innovation-led areas. Consequently, well-known consumer brands like TYLENOL, LISTERINE, and BAND-AID are now part of Kenvue's portfolio. Johnson & Johnson's current operations are centered around two primary divisions: Innovative Medicine and MedTech. The Innovative Medicine segment, formerly known as Pharmaceuticals, specializes in prescription drugs designed to treat complex ailments such as rheumatoid arthritis, various forms of cancer, HIV/AIDS, and neurodegenerative disorders. Its MedTech division, encompassing Medical Devices, delivers cutting-edge technological solutions, including electrophysiology equipment, neurovascular care products, orthopaedic implants for hips, knees, and spine, advanced surgical technologies, and ACUVUE brand disposable contact lenses. These two streamlined segments primarily cater to a client base comprising hospitals, medical professionals, wholesale distributors, and retail outlets. From its headquarters in New Brunswick, New Jersey, Johnson & Johnson continues to uphold its enduring mission of advancing human health, a commitment it has maintained since its founding in 1886.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Joaquin Duato